ClinVar Miner

Submissions for variant NM_000414.4(HSD17B4):c.743G>A (p.Arg248His)

gnomAD frequency: 0.00003  dbSNP: rs748057401
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000493335 SCV000583034 likely pathogenic not provided 2022-05-02 criteria provided, single submitter clinical testing Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 27535533)
Counsyl RCV000671323 SCV000796285 uncertain significance Bifunctional peroxisomal enzyme deficiency 2017-12-15 criteria provided, single submitter clinical testing
Invitae RCV001856978 SCV002258841 likely pathogenic Bifunctional peroxisomal enzyme deficiency; Perrault syndrome 2023-12-17 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 248 of the HSD17B4 protein (p.Arg248His). This variant is present in population databases (rs748057401, gnomAD 0.004%). This missense change has been observed in individual(s) with clinical features of HSD17B4-related conditions (PMID: 34732400). ClinVar contains an entry for this variant (Variation ID: 430263). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on HSD17B4 protein function. This variant disrupts the p.Arg248 amino acid residue in HSD17B4. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16385454, 23308274, 27528516). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002282178 SCV002572320 uncertain significance not specified 2023-12-15 criteria provided, single submitter clinical testing Variant summary: HSD17B4 c.743G>A (p.Arg248His) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 250756 control chromosomes. c.743G>A has been reported in the literature in at least one individual affected with a multisystem progressive disorder, where it was found in compound heterozygosity with a truncating variant (c.590_597dupGATCACGG; p.Met200fs) (Schon_2021). These data alone do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. However, another missense variant affecting the same amino acid (p.Arg248Cys) has been classified as pathogenic by our laboratory in relation to D-Bifunctional Protein Deficiency. The following publication has been ascertained in the context of this evaluation (PMID: 34732400). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Two classified the variant as likely pathogenic, and one classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
Baylor Genetics RCV000671323 SCV004192365 likely pathogenic Bifunctional peroxisomal enzyme deficiency 2023-10-31 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004541543 SCV004765905 uncertain significance HSD17B4-related disorder 2023-11-16 criteria provided, single submitter clinical testing The HSD17B4 c.743G>A variant is predicted to result in the amino acid substitution p.Arg248His. This variant was reported in a compound heterozygous individual with a mitochondrial disorder (Family 66, Table 2, Schon et al 2021. PubMed ID: 34732400). A different variant impacting the same amino acid residue (p.Arg248Cys) has been reported in the homozygous and compound heterozygous state in individuals with D-bifunctional protein deficiency (Mehtälä et al. 2013. PubMed ID: 23308274; Ferdinandusse et al. 2005. PubMed ID: 16385454). This variant is reported in 0.0035% of alleles in individuals of European (Non-Finnish) descent in gnomAD. While this variant could be pathogenic, at this time its clinical significance is interpreted as uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.